UK markets close in 2 hours 25 minutes
  • FTSE 100

    7,356.98
    +17.08 (+0.23%)
     
  • FTSE 250

    23,261.19
    +23.02 (+0.10%)
     
  • AIM

    1,200.04
    -0.01 (-0.00%)
     
  • GBP/EUR

    1.1676
    -0.0071 (-0.61%)
     
  • GBP/USD

    1.3210
    -0.0032 (-0.24%)
     
  • BTC-GBP

    37,147.77
    -1,584.37 (-4.09%)
     
  • CMC Crypto 200

    1,281.60
    -39.68 (-3.00%)
     
  • S&P 500

    4,686.75
    +95.08 (+2.07%)
     
  • DOW

    35,719.43
    +492.40 (+1.40%)
     
  • CRUDE OIL

    72.42
    +0.37 (+0.51%)
     
  • GOLD FUTURES

    1,784.90
    +0.20 (+0.01%)
     
  • NIKKEI 225

    28,860.62
    +405.02 (+1.42%)
     
  • HANG SENG

    23,996.87
    +13.21 (+0.06%)
     
  • DAX

    15,732.28
    -81.66 (-0.52%)
     
  • CAC 40

    7,051.86
    -13.53 (-0.19%)
     

Pfizer CEO on drug pricing: it's a real issue in the U.S.

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In an interview with Yahoo Finance's Anjalee Khemlani, Pfizer CEO Albert Bourla discusses drug pricing in the U.S. and the total cost of medicines to the healthcare system.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting